Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
Alexander ButenkoD.I. Ivanovsky Institute of Virology Division of N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation, Moscow 123098, Russia.
Ivan KholodilovFSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow 108819, Russia.ORCID 0000-0002-3764-7081
Victor LarichevD.I. Ivanovsky Institute of Virology Division of N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation, Moscow 123098, Russia.
Ekaterina LyapeykovaInfectious Clinical Hospital No. 1 of the Moscow City Health Department, Moscow 125310, Russia.
Chumakov Institute of Poliomyelitis and Viral Encephalitides · RUMinistry of Health of the Russian Federation · RUSechenov University · RUInfectious Clinical Hospital No. 1 · RUPirogov Russian National Research Medical University · RU
Funding
Ministry of Science and Higher Education of Russia 0564-2019-0001; 0837-2019-0007 and 0837-2019-0003
6 · The paper itself
Abstract
The tick-borne encephalitis virus (TBEV) is one of the most common members of the
Indexed as
ELISAprotein Erecombinant proteinserodiagnosis of orthoflavivirusesTBEV
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Recombinant TBEV Protein E of the Siberian Subtype Is a Candidate Antigen in the ELISA Test System for Differential Diagnosis. · full record | OpenQuestion